Latest Canadian Market News

Janus Electric boosts its North American footprint with expanded US orders, significant government subsidies slashing conversion costs, and key infrastructure partnerships advancing.

Nufarm Limited posted a 35% rise in underlying net profit after tax to $52.1 million for HY26, driven by margin expansion and cost discipline despite a 5% revenue decline to $1.71 billion. The company confirmed its FY26 outlook, targeting strong earnings growth and leverage reduction.

Orthocell has initiated commercial sales of its Remplir nerve repair device in Canada, leveraging a distributor-led model to penetrate a US$75 million market and setting the stage for broader North American expansion.

Biome Australia’s Activated Probiotics brand surpasses one million boxes sold in Australia, approaches top pharmacy ranking, and launches nationally in Canada, setting the stage for FY26 profitability.

Winsome Resources has advanced its proposed acquisition by Li-FT Power, with shareholder and optionholder meetings scheduled for 5 May 2026 to decide on the scheme of arrangement. The transaction hinges on court approval following a key condition being met.

Temas Resources is tapping the Canadian market with a $1.5 million flow-through share placement aimed at advancing its titanium projects in Quebec. The raise supports exploration expenses tied to its proprietary processing technology and resource development.

Burgundy Diamond Mines’ Canadian subsidiary has expanded its tariff-related loan facility by C$60 million, reinforcing its financial resilience amid ongoing trade tensions.

First Graphene Limited has broadened its North American footprint by appointing SuperGrafeno as its distributor in Canada, targeting the country’s infrastructure sector with its innovative graphene-enhanced cement and concrete products.

4DMedical has rapidly commercialised its CT – VQ™ lung imaging technology following FDA clearance, securing major partnerships and regulatory approvals that position it for significant growth in North America.

PainChek has achieved FDA regulatory clearance enabling its device to qualify for US Remote Therapeutic Monitoring reimbursement, positioning the company for significant growth in the expanding US healthcare market. The company also reports strong global licence growth and a solid pipeline across multiple regions.

Peak Processing has significantly expanded its manufacturing partnership with St. Peter’s Beverages, tripling its SKU production and boosting annual output by up to 700,000 units. This move strengthens its foothold in North America’s cannabis beverage market using proprietary technology.

GrainCorp announces the sale of its Canadian joint venture GrainsConnect to Parrish & Heimbecker for C$150 million, alongside a trading update revealing lower expected grain receivals in Australia’s 2025-26 winter harvest.